
Sign up to save your podcasts
Or


Washington correspondent John Wilkerson joins to discuss why drugmakers have not lobbied against Robert F. Kennedy Jr.'s nomination to lead the Department of Health and Human Services, despite his repeated criticisms of the pharmaceutical industry. We also bring on our colleague Jason Mast to talk about the major hurdles in the field of gene therapy and how one father is trying to overcome them.
By STAT4.5
309309 ratings
Washington correspondent John Wilkerson joins to discuss why drugmakers have not lobbied against Robert F. Kennedy Jr.'s nomination to lead the Department of Health and Human Services, despite his repeated criticisms of the pharmaceutical industry. We also bring on our colleague Jason Mast to talk about the major hurdles in the field of gene therapy and how one father is trying to overcome them.

30,727 Listeners

1,943 Listeners

493 Listeners

9,535 Listeners

6,071 Listeners

390 Listeners

62 Listeners

86 Listeners

33 Listeners

519 Listeners

5,522 Listeners

20 Listeners

51 Listeners

391 Listeners

12 Listeners